HealthCor Catalio Acquisition Corp. (NASDAQ:HCAQ) announced in an 8-K filing that its shareholders approved its combination with medical technology firms Hyperfine and Liminal Sciences, albeit with high redemptions, at a special meeting yesterday.
A total of 17,142,244 shares were redeemed in connection with the vote, removing about $171.4 million from its estimated trust of $207 million heading into the vote. This should not pose any risk to the transaction’s close, however, as the parties agreed to a $125 million minimum cash condition, which was fully met by the deal’s $126.1 million PIPE, regardless of redemptions.
The deal is expected to close later today and the combined entity is expected to begin trading on the Nasdaq on December 23 under the symbol “HYPR”.
The parties initially announced the $580 million combination on July 8. Hyperfine created the first FDA approved portable MR Imaging System which allows the technology to be accessible at anytime, anywhere, and to any patient. Liminal Sciences is building a device to non-invasively measure key vital signs in the brain to enable unprecedented access to dramatically improve patient outcomes.
All measures on HealthCor’s ballot passed by wide margins but about 23% shares dissented against a number of charter proposals. For full vote tallies, click here.
ADVISORS
- J.P. Morgan is acting as exclusive financial advisor to Hyperfine and Liminal.
- Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C. is serving as legal advisor to Hyperfine and Liminal.
- Jefferies LLC acted as financial advisor to HealthCor Catalio Acquisition Corp.
- Jefferies LLC and Evercore Group L.L.C. acted as capital markets advisors and co-lead placement agents to HealthCor Catalio Acquisition Corp. in connection with the private placement.
- Wells Fargo Securities also acted as capital markets advisor and placement agent to HealthCor Catalio Acquisition Corp. in connection with the private placement.
- Kirkland & Ellis LLP and Paul Hastings LLP are serving as legal advisors to HealthCor Catalio Acquisition Corp. and the private placement agents.
Highview Merger Corp. (NASDAQ:HVMCU) announced the pricing of its $200 million IPO and its units are expected to begin trading on the Nasdaq under the symbol “HVMCU”, Tuesday, August 12, 2025. The new SPAC aims to combine with a North American or European business with an excellent management team and a robust outlook for long-term...
McKinley Acquisition Corporation (NASDAQ: MKLYU) announced the pricing of its $150 million IPO and its units are expected to begin trading on the Nasdaq under the symbol “MKLYU”, Tuesday, August 12, 2025. The new SPAC plans to mount a generalist search for a target company with strong fundamentals in a wide range of technology areas....
BoluoC (NASDAQ:LBKXU) has filed for a $60 million SPAC to bring a fresh Asia-based team with blockchain expertise to a target search. The new SPAC is offering investors 1/2 warrant in each unit and a potential shot at a redemption opportunity 18 months after IPO. If the SPAC wishes to extend its lifespan beyond this...
At the SPAC of Dawn With an increasingly thick crowd of crypto treasury deals coming to market via SPACs simultaneously, there was a sign late last week that they may now be coming at a one-in-one-out basis. A proposed combination between Gores X (NASDAQ:GTEN) and Joe McCann-led Solana treasury has reportedly fallen through according to...
An in-depth discussion with Sebastian Bea, President & Head of Investments at ReserveOne, and Vik Mittal, Managing Member at Meteora Capital Partners If there has been one hot summer trend among SPACs, it has been the crypto treasury business combination. To help better understand this new genre of SPAC deal, we sat down with Sebastian...